Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...
Should You Pick MRK Stock At $90?
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
Kennedy to divest interest from HPV vaccine lawsuits
President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...
The New York Times10d
Kennedy Is Keeping His Stake in Vaccine Litigation
Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is ... by the human papillomavirus, or HPV. Mr. Kennedy took the unusual ...
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial
Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.
CBS News7d
What to know about RFK Jr.'s financial ties with a personal injury law firm
continues to support the safety and efficacy profiles of our HPV vaccines," Rahway, New Jersey-based Merck said Tuesday in a statement on the litigation. "The plaintiff's allegations have no merit ...
ABC News7d
In major reversal, Kennedy tells senators he won't take money from vaccine lawsuit
The lawsuit alleges marketing fraud against pharmaceutical company Merck for its HPV vaccine, Gardasil, which Merck denies. The Centers for Disease Control and Prevention (CDC) maintains that the ...